Company Overview and News


Add SYK
to your dashboard

Headline News

MedTech Tax Resumes in 2018, 3 Stocks to Suffer

2018-01-12 zacks
The year 2018 may bring ample reasons for Americans to cheer from the standpoint of the latest Tax Cuts and Jobs Act that was finally signed by the President on Dec 22. Effective Jan 1, there are seven income tax brackets with five offering reduced tax rates. Corporate tax rates too have been slashed to 21% from 35% earlier. This apart, the new legislation has almost doubled the standard deduction. (59-0)

Stryker (SYK) Posts Upbeat Preliminary Sales Figure for Q4

2018-01-12 zacks
Stryker Corporation (SYK - Free Report) recently announced encouraging preliminary net sales results for fourth-quarter 2017 and full-year 2017. The company is scheduled to report fourth-quarter 2017 results on Jan 30, 2018. (46-0)

A Sluggish Spine Market Keeping The Pressure On NuVasive

2018-01-10 seekingalpha
A softer than expected spine market and ongoing pressure in areas like biologics have continued to pressure NuVasive's revenue growth. (23-0)

Entellus (ENTL) Nears 52-Week High: What's Driving It?

2018-01-03 zacks
On Dec 29, 2017, Entellus Medical Inc.’s (ENTL - Free Report) shares reached a high of $25.58, closing the session nominally lower at $24.39. The company’s shares have returned 26.5% over the last year, higher than the S&P 500 index’s gain of 18.3%. Also, shares have outperformed the industry’s gain of 23% over the same time frame. The stock has a market cap of $619.14 million. (35-0)

Stryker's Global Foothold Strong Amid Product Recall Issue

2018-01-03 zacks
On Jan 2, we issued an updated research report on Stryker Corporation (SYK - Free Report) . The company’s solid international foothold is expected to boost growth by expanding existing product offerings in all business segments. However, the company announced the voluntary product recall of the Oral Care line-up in 2017. (16-0)

A New Year And 3 New Dividend Aristocrats

2018-01-02 seekingalpha
Three S&P 500 component stocks just completed their 25th year of dividend growth and are set to join the S&P 500 Dividend Aristocrats. (20-0)

Osiris Therapeutics: Solutions To Challenging Problems

2018-01-02 seekingalpha
Dec. 5, 2017, we learned that the SEC and SDNY investigations are concluded in regards to Osiris. (13-1)

A. O. Smith, S&P Global Expected To Lead 14 Dividend Increases In January

2017-12-31 seekingalpha
Fourteen dividend growth companies I track announced their annual increases in December, including two that deferred their announcements from November. (107-0)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders - ENTL

2017-12-28 accesswire
NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: (7-0)

Inside Johnson & Johnson’s Orthopedic Medical Devices Performance in 3Q17

2017-12-26 marketrealist
In 3Q17, Johnson & Johnson’s (JNJ) hip medical devices generated revenues of $328 million, which reflected a ~2% YoY (year-over-year) rise and a 6% QoQ (quarter-over-quarter) rise. (6-0)

Stryker Corp - Current Holdings - Fintel.io

2017-12-18 fintel.io
Stryker Corp has disclosed 1 total holdings in their latest SEC filings. This investor has not filed a 13F, which indicates it has under $100M in Assets Under Management (AUM). This investor has filed 1 activist 13D filings recently, which suggests it takes an active role in influencing management. Stryker Corp's top industries are "Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks" (sic 38) . (6-0)

Bulletproof Investing Performance: Week 2

2017-12-15 seekingalpha
Each week since the beginning of June, I have presented hedged portfolios for subscribers of my "Bulletproof Investing" service. Each portfolio lasts for 6 months. (281-0)

Penumbra: Undercovered Long Term Growth Play

2017-12-13 seekingalpha
The company has grown the business to a current run rate of $350 million a year, after its first product was only launched a decade ago. (51-0)

Stryker Corporation’s (SYK) Superior Earnings Growth Keep it a Buy

2017-12-12 investorplace
Stryker Corporation (NYSE:SYK) is one of 161 companies within the Health Care Equipment & Supplies GICS industry group, which is in turn part of the 782 company GICS Health Care sector. SYK has a market value of $56.8 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for SYK puts it 28 among the 161 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 92 among the 782 companies in the sector, and number 578 in the nearly 5,000 company Portfolio Grader universe. (6-0)

Deals of the day- Mergers and acquisitions

2017-12-07 reuters
(Adds ArcelorMittal, Kiwi.com, Uniper, Royal KPN, Esaote, Sears, Stryker, British Airways, Nordic Capital, Potash Corp of Saskatchewan, Dialog Semiconductor, BASF, AT&T, Honeywell; updates GVC Holdings) (210-0)

CUSIP: 863667101